ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Novo Holdings establishes rare bleeding disorder firm Hemab pharmatimes
December 16, 2020Novo Holdings’ early-stage investment and company creation team Novo Seeds has established a new portfolio company – Hemab – which will focus on the development of bispecific antibodies for rare bleeding disorders.
Pharma Sources Insight January 2025
